Literature DB >> 11118570

Expression of tenascin-C in astrocytic tumors: its relevance to proliferation and angiogenesis.

C H Kim1, K H Bak, Y S Kim, J M Kim, Y Ko, S J Oh, K M Kim, E K Hong.   

Abstract

BACKGROUND: The expression and distribution of the extracellular matrix protein tenascin-C (TN-C) may be enhanced in human astrocytomas. The purpose of this study is to evaluate the expression of TN-C according to histological malignancy of tumor cells and its relevance to neoplastic angiogenesis in human astrocytic tumors.
METHODS: Between 1994 and 1998, 52 astrocytic tumor specimens including 4 pilocytic astrocytomas, 13 astrocytomas, 3 anaplastic astrocytomas, and 32 glioblastomas were used in this study. A retrospective analysis was performed to evaluate a statistical correlation between TN-C expression and proliferative indices. We characterized the expression of TN-C in neoplastic vessels, around individual tumor cells as a tumor network, and in tumor cells by immunohistochemistry using antibodies against human TN-C. The proliferative indices were also investigated by immunostaining with the MIB-1 antibody against the Ki-67 proliferation antigen.
RESULTS: TN-C immunoreactivity was found to be enhanced in tumor vessels and tumor networks of high-grade astrocytic tumors. The vascular TN-C deposition was greater in high-grade than in low-grade astrocytic tumors (p < 0.05). Its expression was the most intense in glioblastomas. Proliferation indices increased with tumor grade and MIB-1 labeling index (LI) was highest in glioblastomas. Moreover, expression of TN-C in tumor vessels was correlated with proliferative indices.
CONCLUSIONS: Our data show that TN-C in human astrocytic tumors may be identified as a factor contributing to malignant progression. And also, enhanced expression of TN-C in tumor vessels having a high proliferative index indicates that TN-C could be involved in neoplastic angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11118570     DOI: 10.1016/s0090-3019(00)00307-4

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  16 in total

1.  Interaction of angiogenic microvessels with the extracellular matrix.

Authors:  Laxminarayanan Krishnan; James B Hoying; Hoa Nguyen; Helen Song; Jeffrey A Weiss
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-10-12       Impact factor: 4.733

2.  Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas.

Authors:  Peter Hau; Leoni A Kunz-Schughart; Petra Rümmele; Füsun Arslan; Anett Dörfelt; Horst Koch; Annette Lohmeier; Birgit Hirschmann; Adolf Müller; Ulrich Bogdahn; Anja-Katrin Bosserhoff
Journal:  J Neurooncol       Date:  2005-11-15       Impact factor: 4.130

Review 3.  Mechanical interaction of angiogenic microvessels with the extracellular matrix.

Authors:  Lowell T Edgar; James B Hoying; Urs Utzinger; Clayton J Underwood; Laxminarayanan Krishnan; Brenda K Baggett; Steve A Maas; James E Guilkey; Jeffrey A Weiss
Journal:  J Biomech Eng       Date:  2014-02       Impact factor: 2.097

Review 4.  Tenascins and the importance of adhesion modulation.

Authors:  Ruth Chiquet-Ehrismann; Richard P Tucker
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-05-01       Impact factor: 10.005

5.  Tenascin-C in primary Merkel cell carcinoma.

Authors:  V Koljonen; T Jahkola; E Tukiainen; G Granroth; C Haglund; T Böhling
Journal:  J Clin Pathol       Date:  2005-03       Impact factor: 3.411

Review 6.  Role of tenascins in the ECM of gliomas.

Authors:  Nicole Brösicke; Andreas Faissner
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

7.  Distribution pattern of tenascin-C in glioblastoma: correlation with angiogenesis and tumor cell proliferation.

Authors:  Senija Behrem; Kamelija Zarković; Neven Eskinja; Nives Jonjić
Journal:  Pathol Oncol Res       Date:  2005-12-31       Impact factor: 3.201

8.  Brevican, neurocan, tenascin-C and versican are mainly responsible for the invasiveness of low-grade astrocytoma.

Authors:  Imre Varga; Gábor Hutóczki; Csaba D Szemcsák; Gábor Zahuczky; Judit Tóth; Zsolt Adamecz; Annamária Kenyeres; László Bognár; Zoltán Hanzély; Almos Klekner
Journal:  Pathol Oncol Res       Date:  2011-10-14       Impact factor: 3.201

Review 9.  Manipulating the microvasculature and its microenvironment.

Authors:  Laxminarayanan Krishnan; Carlos C Chang; Sara S Nunes; Stuart K Williams; Jeffrey A Weiss; James B Hoying
Journal:  Crit Rev Biomed Eng       Date:  2013

10.  Locoregional radioimmunotherapy in selected patients with malignant glioma: experiences, side effects and survival times.

Authors:  C Goetz; P Riva; G Poepperl; F J Gildehaus; A Hischa; K Tatsch; H J Reulen
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.